Skip to main content
Premium Trial:

Request an Annual Quote

U Pitt Team to Use Wafergen’s Whole-Genome RT-PCR Platform for Biomarker Studies

NEW YORK (GenomeWeb News) — The University of Pittsburgh Medical School will serve as the alpha test site for Wafergen Biosystem’s real-time PCR system, Wafergen said today.
 
Through a research collaboration with a team led by Department of Medicine Chairman Steven Shapiro, the school will use the WaferGen SmartChip Real-Time PCR System in its efforts to identify biomarkers that are therapeutically useful for chronic obstructive pulmonary disease and for lung cancer.
 
Wafergen said the SmartChip “is designed as the first whole-genome, high-throughput gene expression real-time polymerase chain reaction platform.”
 
Financial terms of the collaboration were not released.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.